Skip to content
X-linked adrenoleukodystrophy
EntityQ366964· pop 29· linked from 285 articles

X-linked adrenoleukodystrophy

Sign in to save

Also known as ALD, Adrenoleukodystrophy, Bronze Schilder disease, Encephalitis periaxialis concentrica, Encephalitis periaxialis, Schilder's, SUDANOPHILIC CEREBRAL SCLEROSIS, Schilder disease, Siemerling-Creutzfeldt Disease

Adrenoleukodystrophy (ALD) is a disease linked to the X chromosome. It is a result of fatty acid buildup caused by failure of peroxisomal fatty acid beta oxidation which results in the accumulation of very long chain fatty acids in tissues throughout the body. The most severely affected tissues are the myelin in the central nervous system, the adrenal cortex, and the Leydig cells in the testes. The long chain fatty acid buildup causes damage to the myelin sheath of the neurons of the brain, resulting in seizures and hyperactivity. Other symptoms include problems in speaking, listening, and und

Key facts

Medical condition.name
Adrenoleukodystrophy
Medical condition.synonyms
X-linked adrenoleukodystrophy, ALD, X-ALD, Siemerling–Creutzfeldt disease, bronze Schilder disease
Medical condition.image
Adrenoleukodystrophy.jpg
Medical condition.caption
White matter, with reduced volume and increased signal intensity. The anterior white matter is spared. Features are consistent with X-linked adrenoleukodystrophy.
Medical condition.field
Medical genetics
Medical condition.types
X-Linked ALD

via Wikipedia infobox

Research

2,959 papers

via PubMed

Wikidata facts

Subclass of
disease
Named after
Thomas Addison
Show 9 more facts
health specialty
genetics
Commons category
Adrenoleukodystrophy
NCI Thesaurus ID
C61252
ICD-9-CM
341.1
external data available at URL
www.nanbyou.or.jp/entry/186
genetic association
ABCD1
on focus list of Wikimedia project
WikiProject Medicine
drug or therapy used for treatment
Lorenzo's oil
Sources (9)

via Wikidata · CC0

~19 min read

Encyclopedic overview

16 sections
Contents
  • Signs and symptoms
  • Male adrenoleukodystrophy phenotypes
  • Female adrenoleukodystrophy phenotypes
  • Genetics
  • Pathogenesis
  • Diagnosis
  • Treatments
  • Dietary therapy
  • Transplant
  • Gene therapy
  • Drugs
  • Adrenal insufficiency
  • Epidemiology
  • Asymptomology
  • References
  • External links

Adrenoleukodystrophy (ALD) is a disease linked to the X chromosome. It is a result of fatty acid buildup caused by failure of peroxisomal fatty acid beta oxidation which results in the accumulation of very long chain fatty acids in tissues throughout the body. The most severely affected tissues are the myelin in the central nervous system, the adrenal cortex, and the Leydig cells in the testes. The long chain fatty acid buildup causes damage to the myelin sheath of the neurons of the brain, resulting in seizures and hyperactivity. Other symptoms include problems in speaking, listening, and understanding verbal instructions.

Clinically, ALD presents as a heterogeneous disorder, showing several distinct phenotypes, and no clear pattern of genotype–phenotype correlation. As an X-linked disorder, ALD presents more frequently and severely in males; however, approximately 80% of heterozygote females show some symptoms later in life. Approximately one third of male ALD patients will present with the childhood cerebral form of the disease, which is the most severe form. It is characterized by normal development in early childhood, followed by rapid degeneration to a vegetative state. The other forms of ALD vary in timing of onset and in clinical severity, ranging from adrenal insufficiency alone to progressive paraparesis in early adulthood.

Excerpted from Wikipedia’s “X-linked adrenoleukodystrophy” article, available under the CC BY-SA 4.0 licence.

Gallery (2)